secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRATED BIOPHARMA INC (INBP)
CIK:        0001016504
Form:       8-K
Filed at:   2024-12-02T23:59:59+00:00
Accession:  0001437749-24-036441
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integrated BioPharma elects two Class I directors, ratifies Marcum as auditor at 2024 annual meeting
--------------------------------------------------------------------------------

- Elected Damon DeSantis as Class I director: 20,448,871 for, 142,036 withheld, 1,342,353 broker non-votes.
- Elected Riva Sheppard as Class I director: 20,301,671 for, 289,236 withheld, 1,342,353 broker non-votes.
- Ratified appointment of Marcum LLP as independent auditor for FY2025: 21,905,273 for, 9,287 against, 18,700 abstain.
- Total shares voted: 21,933,260 of 30,099,610 entitled; quorum present.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1016504/000143774924036441/0001437749-24-036441-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1016504/000143774924036441/inbp20241202_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-036441

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer